BRPI0911659A2 - composto 3-fenilpirazolo[5,1-b]tiazol - Google Patents

composto 3-fenilpirazolo[5,1-b]tiazol

Info

Publication number: BRPI0911659A2
Authority: BR; Brazil
Prior art keywords: phenylpyrazolo; thiazole compound; thiazole; compound
Prior art date: 2008-04-15

Application number

BRPI0911659A

Other languages

English (en)

Inventor

Akira Inomata

Hisashi Shibata

Kodo Shikata

Kogyoku Shin

Kunitoshi Takeda

Minako Hashizume

Taro Terauchi

Yoshinori Takahashi

Original Assignee

Eisai R&D Man Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-15

Filing date

2009-04-09

Publication date

2015-10-13

2009-04-09 Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd

2015-10-13 Publication of BRPI0911659A2 publication Critical patent/BRPI0911659A2/pt

2020-08-25 Publication of BRPI0911659B1 publication Critical patent/BRPI0911659B1/pt

2021-05-25 Publication of BRPI0911659B8 publication Critical patent/BRPI0911659B8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Addiction (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0911659A 2008-04-15 2009-04-09 composto 3-fenilpirazolo[5,1-b]tiazol e composição farmacêutica compreendendo o mesmo BRPI0911659B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4508408P	2008-04-15	2008-04-15
US61/045,084		2008-04-15
JP2008106080		2008-04-15
JP2008-106080		2008-04-15
PCT/JP2009/057270 WO2009128383A1 (ja)	2008-04-15	2009-04-09	３－フェニルピラゾロ［５，１－ｂ］チアゾール化合物

Publications (3)

Publication Number	Publication Date
BRPI0911659A2 true BRPI0911659A2 (pt)	2015-10-13
BRPI0911659B1 BRPI0911659B1 (pt)	2020-08-25
BRPI0911659B8 BRPI0911659B8 (pt)	2021-05-25

Family

ID=41164535

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0911659A BRPI0911659B8 (pt)	2008-04-15	2009-04-09	composto 3-fenilpirazolo[5,1-b]tiazol e composição farmacêutica compreendendo o mesmo

Country Status (28)

Country	Link
US (1)	US8431603B2 (pt)
EP (1)	EP2266990B1 (pt)
JP (1)	JP4654325B2 (pt)
KR (1)	KR101601994B1 (pt)
CN (1)	CN102007133B (pt)
AR (1)	AR071655A1 (pt)
AU (1)	AU2009237050B2 (pt)
BR (1)	BRPI0911659B8 (pt)
CA (1)	CA2721670C (pt)
CL (1)	CL2009000896A1 (pt)
CY (1)	CY1113484T1 (pt)
DK (1)	DK2266990T3 (pt)
ES (1)	ES2396126T3 (pt)
HR (1)	HRP20121021T1 (pt)
IL (1)	IL208393A (pt)
MX (1)	MX2010011089A (pt)
MY (1)	MY152687A (pt)
NZ (1)	NZ588376A (pt)
PE (1)	PE20091890A1 (pt)
PL (1)	PL2266990T3 (pt)
PT (1)	PT2266990E (pt)
RS (1)	RS52561B (pt)
RU (1)	RU2482120C2 (pt)
SI (1)	SI2266990T1 (pt)
TW (1)	TW201004964A (pt)
UA (1)	UA101836C2 (pt)
WO (1)	WO2009128383A1 (pt)
ZA (1)	ZA201006764B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2266990T3 (pl)	2008-04-15	2013-03-29	Eisai R&D Man Co Ltd	ZWIĄZEK 3-FENYLOPIRAZOLO[5,1-b] TIAZOLOWY
WO2011043387A1 (ja)	2009-10-08	2011-04-14	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピラゾロオキサゾール化合物
AR078521A1 (es)	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
CN102020587A (zh) *	2010-11-25	2011-04-20	大连凯飞精细化工有限公司	2-甲氧基-4-氰基苯甲醛的合成方法
TWI679205B (zh) *	2014-09-02	2019-12-11	日商日本新藥股份有限公司	吡唑并噻唑化合物及醫藥
CN115010621B (zh) *	2022-07-21	2023-11-03	山东百启生物医药有限公司	一种4-溴-3-甲基苯甲腈的合成方法

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US224974A (en)		1880-02-24		wheeler
JPS5320360B2 (pt)	1973-05-30	1978-06-26
JPS51141896A (en) *	1975-05-31	1976-12-07	Sankyo Co Ltd	Process for preparing fused ring triazoropyrimidine derivatives
EP0068378B1 (en)	1981-06-26	1986-03-05	Schering Corporation	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4596872A (en) *	1985-06-05	1986-06-24	Schering A.G.	Imidazo[1,2-a]pyridines, and process for their preparation
FR2594438B1 (fr) *	1986-02-14	1990-01-26	Labaz Sanofi Nv	Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
US5190862A (en) *	1987-04-01	1993-03-02	Boehringer Mannheim Gmbh	Chromogenic compounds and the use thereof as enzyme substrates
US4925849A (en) *	1987-06-15	1990-05-15	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines
US5179103A (en) *	1987-06-15	1993-01-12	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines
FR2619818B1 (fr) *	1987-09-01	1990-01-12	Sanofi Sa	Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
US5155114A (en) *	1989-01-23	1992-10-13	Fujisawa Pharmaceutical Company, Ltd.	Method of treatment using pyrazolopyridine compound
US5338743A (en) *	1988-06-06	1994-08-16	Fujisawa Pharmaceutical Co., Ltd.	New use of the adenosine antagonist
JPH0276880A (ja)	1988-06-16	1990-03-16	Sankyo Co Ltd	悪液質改善治療剤
US5127936A (en) *	1988-07-19	1992-07-07	E. I. Du Pont De Nemours And Company	Substituted phenyltriazolopyrimidine herbicides
KR900701787A (ko)	1988-07-19	1990-12-04	제임스 제이. 플린	치환된 페닐트리아졸로피리미딘 제초제
CA1330079C (en)	1988-10-13	1994-06-07	Michihiko Tsujitani	Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
JPH0688999B2 (ja)	1988-10-13	1994-11-09	ポーラ化成工業株式会社	ピロロ〔３，２―ｅ〕ピラゾロ〔１，５―ａ〕ピリミジン誘導体およびこれを含有する医薬
JPH085790B2 (ja)	1988-11-11	1996-01-24	杏林製薬株式会社	記憶障害改善薬
GB8901423D0 (en)	1989-01-23	1989-03-15	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof
WO1990011966A1 (en) *	1989-04-04	1990-10-18	Frederica Catharina Newman	Equestrian training aid and method for using the same
DE3942357A1 (de)	1989-12-21	1991-06-27	Boehringer Mannheim Gmbh	3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel
DE3942356A1 (de) *	1989-12-21	1991-06-27	Boehringer Mannheim Gmbh	Verwendung von 1-arylsemicarbaziden zur stabilisierung von enzymsubstraten, entsprechende verfahren und diagnostisches mittel enthaltend einen solchen stabilisator
DE3942355A1 (de) *	1989-12-21	1991-06-27	Boehringer Mannheim Gmbh	N- und o-substituierte aminophenolderivate, zwischenprodukte zu deren herstellung, deren verwendung als hydrolasesubstrate, ein entsprechendes bestimmungsverfahren und hierfuer geeignetes diagnostisches mittel
CA2060138A1 (en)	1991-01-29	1992-07-30	Youichi Shiokawa	New use of the adenosine antagonist
JP3295149B2 (ja)	1991-12-26	2002-06-24	ポーラ化成工業株式会社	ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体
FR2687675B1 (fr) *	1992-01-31	1997-04-18	Roussel Uclaf	Nouveaux derives bicycliques de la pyridine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
JPH05271338A (ja)	1992-03-27	1993-10-19	Nippon Zeon Co Ltd	二置換ジフェニルアセチレン系重合体
WO1993025553A1 (en) *	1992-06-17	1993-12-23	The Upjohn Company	Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
TW336932B (en)	1992-12-17	1998-07-21	Pfizer	Amino-substituted pyrazoles
TW444018B (en)	1992-12-17	2001-07-01	Pfizer	Pyrazolopyrimidines
PL175831B1 (pl)	1992-12-17	1999-02-26	Pfizer	Pochodna pirazolu
PL176526B1 (pl)	1992-12-17	1999-06-30	Pfizer	Pirolopirymidyny jako związki o działaniu antagonistów czynnika uwalniającego kortykotropinę
ATE187451T1 (de)	1992-12-17	1999-12-15	Pfizer	Substituierte pyrazole als crf antagonisten
FR2701708B1 (fr)	1993-02-19	1995-05-19	Sanofi Elf	Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
DE4311460A1 (de) *	1993-04-08	1994-10-13	Boehringer Mannheim Gmbh	Verfahren zur kolorimetrischen Bestimmung eines Analyten mittels Benzylalkoholdehydrogenase und einem chromogenen Redoxindikator
CN1142817A (zh)	1993-10-12	1997-02-12	杜邦麦克制药有限公司	1n-烷基-n-芳基嘧啶胺及其衍生物
FR2714059B1 (fr)	1993-12-21	1996-03-08	Sanofi Elf	Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JP2891544B2 (ja)	1994-06-16	1999-05-17	ファイザー・インコーポレーテッド	ピラゾロおよびピロロピリジン類
US5955613A (en)	1995-10-13	1999-09-21	Neurogen Corporation	Certain pyrrolopyridine derivatives; novel CRF1 specific ligands
EP0778277B1 (en)	1995-12-08	2003-06-25	Pfizer Inc.	Substituted heterocyclic derivatives as CRF antagonists
US6664261B2 (en) *	1996-02-07	2003-12-16	Neurocrine Biosciences, Inc.	Pyrazolopyrimidines as CRF receptor antagonists
DE69708059T2 (de)	1996-02-07	2002-07-18	Janssen Pharmaceutica N.V., Beerse	Thiophenopyrimidine
PT880523E (pt)	1996-02-07	2007-01-31	Neurocrine Biosciences Inc	Pirazolopirimidinas com antagonistas dos receptores de crf
ZA973884B (en)	1996-05-23	1998-11-06	Du Pont Merck Pharma	Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
US6022978A (en)	1996-06-11	2000-02-08	Pfizer Inc.	Benzimidazole derivatives
JP3621706B2 (ja)	1996-08-28	2005-02-16	ファイザー・インク	置換された６，５―ヘテロ―二環式誘導体
US20010007867A1 (en) *	1999-12-13	2001-07-12	Yuhpyng L. Chen	Substituted 6,5-hetero-bicyclic derivatives
JPH10218881A (ja)	1997-02-03	1998-08-18	Pola Chem Ind Inc	新規なピロロピラゾロピリミジン誘導体
WO1998035967A2 (en)	1997-02-18	1998-08-20	Neurocrine Biosciences, Inc.	Biazacyclic crf antagonists
JPH1143434A (ja)	1997-05-30	1999-02-16	Pola Chem Ind Inc	カリウムチャンネル開口薬
IL133800A0 (en)	1997-07-03	2001-04-30	Du Pont Pharm Co	Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
AU9021598A (en)	1997-08-22	1999-03-16	Du Pont Pharmaceuticals Company	Nitrogen substituted imidazo{4,5-c}pyrazoles as corticotropin relea sing hormone antagonists
MY153569A (en)	1998-01-20	2015-02-27	Mitsubishi Tanabe Pharma Corp	Inhibitors of ?4 mediated cell adhesion
AU2298599A (en)	1998-02-04	1999-08-23	Nissan Chemical Industries Ltd.	Pyridine derivatives fused with azole and herbicide
US6365589B1 (en)	1998-07-02	2002-04-02	Bristol-Myers Squibb Pharma Company	Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6271380B1 (en)	1998-12-30	2001-08-07	Dupont Pharmaceuticals Company	1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
AU4331500A (en)	1999-04-06	2000-10-23	Du Pont Pharmaceuticals Company	Pyrazolotriazines as crf antagonists
WO2000059908A2 (en)	1999-04-06	2000-10-12	Du Pont Pharmaceuticals Company	Pyrazolopyrimidines as crf antagonists
JP3795305B2 (ja)	1999-07-19	2006-07-12	田辺製薬株式会社	医薬組成物
SE9903760D0 (sv) *	1999-10-18	1999-10-18	Astra Ab	New compounds
CZ20021242A3 (cs)	1999-10-08	2002-08-14	Grünenthal GmbH	Bicyklické deriváty imidazo-5-yl-aminu, způsob jejich výroby, jejich pouľití a léčiva tyto látky obsahující
MXPA02003547A (es) *	1999-10-08	2002-09-18	Gr Nenthal Gmbh	Derivados biciclos de imidazo-3-il-amina substituidos en el sexto anillo.
DE19948434A1 (de) *	1999-10-08	2001-06-07	Gruenenthal Gmbh	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
AU779197B2 (en) *	1999-10-08	2005-01-13	Grunenthal Gmbh	Bicyclic imidazo-3-yl-amine derivatives
FR2801308B1 (fr) *	1999-11-19	2003-05-09	Oreal	COMPOSITIONS DE TEINTURE DE FIBRES KERATINIQUES CONTENANT DE DES 3-AMINO PYRAZOLO-[1,(-a]-PYRIDINES, PROCEDE DE TEINTURE, NOUVELLES 3-AMINO PYRAZOLO-[1,5-a]-PYRIDINES
EP1244666A1 (en)	1999-12-17	2002-10-02	Bristol-Myers Squibb Pharma Company	Imidazopyrimidinyl and imidazopyridinyl derivatives
WO2002006286A2 (en)	2000-07-14	2002-01-24	Bristol-Myers Squibb Pharma Company	IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
MY129000A (en)	2000-08-31	2007-03-30	Tanabe Seiyaku Co	INHIBITORS OF a4 MEDIATED CELL ADHESION
JP3617433B2 (ja)	2000-09-05	2005-02-02	株式会社デンソー	駆動回路
BR0206698A (pt)	2001-01-26	2004-04-20	Bristol Myers Squibb Co	Derivados de imidazolila como inibidores de fator de liberação de corticotropina.
TWI312347B (en) *	2001-02-08	2009-07-21	Eisai R&D Man Co Ltd	Bicyclic nitrogen-containing condensed ring compounds
DK2272813T3 (en) *	2001-04-24	2017-02-27	Massachusetts Inst Of Tech (Mit)	COPPER CATALYST CREATION OF CARBON OXYGEN COMPOUNDS
NZ529333A (en) *	2001-04-27	2005-01-28	Eisai Co Ltd	Pyrazolo[1,5-a]pyridines and medicines containing the same
DE60214427T2 (de)	2001-12-19	2007-04-26	Flexitral Inc.	Verbesserte geruchsstoffe
MY140707A (en)	2002-02-28	2010-01-15	Mitsubishi Tanabe Pharma Corp	Process for preparing a phenylalanine derivative and intermediates thereof
EP1485384A1 (en)	2002-03-13	2004-12-15	Pharmacia & Upjohn Company LLC	Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
EP1518187A1 (de)	2002-07-01	2005-03-30	Ognjen Amidzic	Verfahren zur erstellung von daten, die für die beurteilung kognitiver oder sensomotorischer leistungsfähigkeiten oder leistungen von testpersonen verwendbar sind
JP2004053678A (ja)	2002-07-16	2004-02-19	Toyobo Co Ltd	Ｉｒアブレーション用積層体
US7176216B2 (en) *	2002-10-22	2007-02-13	Eisai Co., Ltd.	7-phenylpyrazolopyridine compounds
BRPI0313976B8 (pt)	2002-10-22	2021-05-25	Eisai Co Ltd	compostos de 7-fenilpirazolopiridina e uso dos mesmos na preparação de agente terapêutico ou profilático para doenças associadas com o crf ou seus receptores
WO2005063756A1 (en) *	2003-12-22	2005-07-14	Sb Pharmco Puerto Rico Inc	Crf receptor antagonists and methods relating thereto
WO2005079868A2 (en) *	2004-02-13	2005-09-01	Sb Pharmco Puerto Rico Inc	Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses
JP4832743B2 (ja)	2004-03-29	2011-12-07	ケンブリッジユニバーシティテクニカルサービスリミテッド	化合物の合成方法および合成反応触媒
JP4520215B2 (ja)	2004-04-30	2010-08-04	日油株式会社	分子量が制御された置換ジフェニルアセチレン重合体の製造方法
GB0519957D0 (en)	2005-09-30	2005-11-09	Sb Pharmco Inc	Chemical compound
US8088779B2 (en) *	2005-09-30	2012-01-03	Smithkline Beecham (Cork) Limited	Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
PL2266990T3 (pl)	2008-04-15	2013-03-29	Eisai R&D Man Co Ltd	ZWIĄZEK 3-FENYLOPIRAZOLO[5,1-b] TIAZOLOWY
US7994203B2 (en)	2008-08-06	2011-08-09	Novartis Ag	Organic compounds
JP2010235929A (ja)	2009-03-09	2010-10-21	Sumitomo Chemical Co Ltd	重合体
TWI358017B (en)	2009-12-17	2012-02-11	Askey Computer Corp	Electronic device loading base

2009
- 2009-04-09 PL PL09732907T patent/PL2266990T3/pl unknown
- 2009-04-09 CA CA2721670A patent/CA2721670C/en active Active
- 2009-04-09 RS RS20120562A patent/RS52561B/sr unknown
- 2009-04-09 KR KR1020107019769A patent/KR101601994B1/ko not_active Expired - Fee Related
- 2009-04-09 AU AU2009237050A patent/AU2009237050B2/en not_active Ceased
- 2009-04-09 CN CN2009801131303A patent/CN102007133B/zh not_active Expired - Fee Related
- 2009-04-09 NZ NZ588376A patent/NZ588376A/en not_active IP Right Cessation
- 2009-04-09 US US12/421,182 patent/US8431603B2/en not_active Expired - Fee Related
- 2009-04-09 WO PCT/JP2009/057270 patent/WO2009128383A1/ja not_active Ceased
- 2009-04-09 EP EP09732907A patent/EP2266990B1/en active Active
- 2009-04-09 JP JP2010508183A patent/JP4654325B2/ja not_active Expired - Fee Related
- 2009-04-09 SI SI200930453T patent/SI2266990T1/sl unknown
- 2009-04-09 MY MYPI20104527 patent/MY152687A/en unknown
- 2009-04-09 BR BRPI0911659A patent/BRPI0911659B8/pt not_active IP Right Cessation
- 2009-04-09 DK DK09732907.2T patent/DK2266990T3/da active
- 2009-04-09 HR HRP20121021AT patent/HRP20121021T1/hr unknown
- 2009-04-09 ES ES09732907T patent/ES2396126T3/es active Active
- 2009-04-09 RU RU2010146240/04A patent/RU2482120C2/ru active
- 2009-04-09 MX MX2010011089A patent/MX2010011089A/es active IP Right Grant
- 2009-04-09 PT PT97329072T patent/PT2266990E/pt unknown
- 2009-04-10 TW TW098112062A patent/TW201004964A/zh unknown
- 2009-04-13 PE PE2009000505A patent/PE20091890A1/es not_active Application Discontinuation
- 2009-04-13 AR ARP090101280A patent/AR071655A1/es not_active Application Discontinuation
- 2009-04-14 CL CL2009000896A patent/CL2009000896A1/es unknown
- 2009-09-04 UA UAA201013461A patent/UA101836C2/ru unknown
2010
- 2010-09-21 ZA ZA2010/06764A patent/ZA201006764B/en unknown
- 2010-10-03 IL IL208393A patent/IL208393A/en active IP Right Grant
2012
- 2012-12-21 CY CY20121101254T patent/CY1113484T1/el unknown

Also Published As

Publication number	Publication date
US20090259049A1 (en)	2009-10-15
UA101836C2 (en)	2013-05-13
ES2396126T3 (es)	2013-02-19
CN102007133B (zh)	2013-06-12
BRPI0911659B1 (pt)	2020-08-25
TW201004964A (en)	2010-02-01
EP2266990B1 (en)	2012-09-26
PE20091890A1 (es)	2009-12-20
CN102007133A (zh)	2011-04-06
RS52561B (sr)	2013-04-30
CA2721670A1 (en)	2009-10-22
HRP20121021T1 (hr)	2013-01-31
EP2266990A4 (en)	2011-08-03
IL208393A0 (en)	2010-12-30
IL208393A (en)	2013-08-29
AU2009237050B2 (en)	2013-04-11
SI2266990T1 (sl)	2013-01-31
PT2266990E (pt)	2012-12-27
HK1150310A1 (en)	2011-11-25
HK1151797A1 (en)	2012-02-10
US8431603B2 (en)	2013-04-30
JP4654325B2 (ja)	2011-03-16
ZA201006764B (en)	2012-03-28
RU2482120C2 (ru)	2013-05-20
AU2009237050A1 (en)	2009-10-22
RU2010146240A (ru)	2012-05-20
CY1113484T1 (el)	2016-06-22
MY152687A (en)	2014-10-31
CA2721670C (en)	2013-09-10
AR071655A1 (es)	2010-07-07
DK2266990T3 (da)	2013-01-07
JPWO2009128383A1 (ja)	2011-08-04
MX2010011089A (es)	2010-11-05
KR20110002007A (ko)	2011-01-06
WO2009128383A1 (ja)	2009-10-22
KR101601994B1 (ko)	2016-03-17
BRPI0911659B8 (pt)	2021-05-25
PL2266990T3 (pl)	2013-03-29
NZ588376A (en)	2011-06-30
EP2266990A1 (en)	2010-12-29
CL2009000896A1 (es)	2010-04-16

Publication	Publication Date	Title
BRPI0815042A2 (pt)	2015-02-10	Compostos de pirazol
EP2193127A4 (en)	2011-09-14	BENZOTHIAZOLE COMPOUNDS
BRPI0815717A2 (pt)	2015-02-10	Compostos de imidazopirazina.
ATE555107T1 (de)	2012-05-15	2-aza-bicyclo-ä2,2,1-üheptan-derivate
BRPI0813500A2 (pt)	2015-01-06	Compostos antivirais
BRPI0821086A2 (pt)	2014-10-07	Compostos inseticidas
BRPI0907563A2 (pt)	2015-08-04	Derivados de 4,5-di-hidro-xazol-2-il amina
ATE524477T1 (de)	2011-09-15	Aziridinylepothilonverbindungen
BRPI0922464A2 (pt)	2015-08-11	Combinações de compostos ativos
BRPI0811264A2 (pt)	2014-11-04	Compostos
BRPI0817579A2 (pt)	2015-04-07	Derivados de tiazol
BRPI0809996A2 (pt)	2014-10-14	Compostos
BRPI0814424A2 (pt)	2015-01-06	Compostos heterociclila
BRPI0923592A2 (pt)	2016-01-26	composto
BRPI0912716A2 (pt)	2015-10-13	composto.
DK2220060T3 (da)	2017-01-02	Tetrahydrobenzothiazolderivater
BRPI0815181A2 (pt)	2015-03-31	Compostos
BRPI0911393A2 (pt)	2015-12-29	composto de 5-hidroxipirimidina-4-carboxamida
BRPI0820831A2 (pt)	2014-12-23	Combinações de composto ativo
BRPI0911659A2 (pt)	2015-10-13	composto 3-fenilpirazolo[5,1-b]tiazol
BRPI0916395A2 (pt)	2016-02-16	compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
PT2792662T (pt)	2016-07-07	Compostos de morfinano
BRPI0814613A2 (pt)	2015-01-27	Compostos
BRPI0909461A2 (pt)	2015-08-04	Composto de enaminotiocarbonila substituídos
BRPI0913805A2 (pt)	2016-11-01	composto

Legal Events

Date	Code	Title	Description
2018-03-06	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-02-18	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-03-03	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-06-30	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-08-25	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/08/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2025-02-04	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 16A ANUIDADE.
2025-06-17	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.